Accessibility Menu
 
Evolutionary Genomics logo

Evolutionary Genomics

(OTC) FNAM

Current Price$0.00
Market Cap$1,300
Since IPO (2015)-100%
5 Year-100%
1 Year-75%
1 Month+0%

Evolutionary Genomics Financials at a Glance

Market Cap

$1,300

Revenue (TTM)

$0.00

Net Income (TTM)

$1.86M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-11.63 (Low)

Price

$0.00

Volume

1,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

FNAM News

No articles available.

FNAM: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Evolutionary Genomics

Industry

Biotechnology

Employees

4

CEO

Steve Warnecke, CPA

Headquarters

Castle Rock, CO 80108, US

FNAM Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

-93%

Return on Assets

-82%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.30K

Shares Outstanding

6.66M

Volume

1.00K

Short Interest

0.00%

Avg. Volume

0

Financials (TTM)

Gross Profit

$1.02M

Operating Income

$2.01M

EBITDA

$913.47K

Operating Cash Flow

$640.95K

Capital Expenditure

$3.00

Free Cash Flow

$640.95K

Cash & ST Invst.

$577.07K

Total Debt

$3.74M

Evolutionary Genomics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2022YOY CHG

Revenue

$0.00

N/A

Gross Profit

$255.37K

+1.7%

Gross Margin

0.00%

N/A

Market Cap

$1.30K

N/A

Market Cap/Employee

$650.00

N/A

Employees

2

N/A

Net Income

$254.77K

+61.9%

EBITDA

$156.87K

+61.6%

Quarterly Fundamentals

Name
Q4 2022YOY CHG

Net Cash

$3.17M

+10.3%

Accounts Receivable

$78.00K

N/A

Inventory

$0.00

N/A

Long Term Debt

$3.74M

+0.0%

Short Term Debt

$0.00

N/A

Return on Assets

-82.21%

N/A

Return on Invested Capital

-92.59%

N/A

Free Cash Flow

$188.48K

+51.9%

Operating Cash Flow

$188.48K

+51.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CLABFCore One Labs Inc.
$0.00+0.00%
REPCFRepliCel Life Sciences Inc.
$0.00+0.00%
SIGYSigyn Therapeutics, Inc.
$0.04+50.00%
SRNESorrento Therapeutics, Inc.
$0.00-13.89%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$43.87-0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%
QQQInvesco QQQ Trust
$582.06-0.02%

Questions About FNAM

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.